ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1019

Cigarette Smoking Induces Post-translational Protein Modifications in Both in Vitro and in Vivo Models of Rheumatoid Arthritis-associated Interstitial Lung Disease

Alyssa Gregory1, Corrine Kliment1, Geoffrey Thiele2, Michael Duryee2, Ted Mikuls2, Bryant England2, Jill Poole2 and Dana Ascherman3, 1University of Pittsburgh School of Medicine, Pittsburgh, PA, 2University of Nebraska Medical Center, Omaha, NE, 3University of Pittsburgh, Pittsburgh, PA

Meeting: ACR Convergence 2021

Keywords: Animal Model, genetics, interstitial lung disease, rheumatoid arthritis, Smoking

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: RA – Animal Models Poster (1014–1021)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Cigarette smoking has been epidemiologically linked to the development of ACPA+ rheumatoid arthritis (RA) and, by extension, RA-associated interstitial lung disease (RA-ILD). Providing strong evidence for the contribution of gene-environment interactions to disease pathogenesis, the risk for ACPA+ RA is increased more than 20 fold in cigarette smokers who also possess HLA-DRB1*0401 or other shared epitope alleles. This link between smoking, the shared epitope, and risk of RA/RA-ILD is thought to arise from immune responses targeting in situ, smoking-induced post-translational modifications (PTMs) such as citrullination. However, because most of the data linking smoking and PTMs has been “associative,” we examined the ability of cigarette smoke to directly induce PTMs in both in vitro and in vivo model systems.

Methods: Primary human bronchial epithelial cells (HBEs) were isolated, cultured at the air-liquid interface, and robotically exposed to defined doses of cigarette smoke vs. air prior to harvesting and preparation of cell extracts. Following SDS-PAGE, separated proteins were transferred to nitrocellulose membranes and probed with anti-modified citrulline antibody (EMD Millipore). Alternatively, extracts were transferred directly to membranes and probed with polyclonal antibody recognizing malondialdehyde-acetaldehyde (MAA)-modified proteins. Complementing these in vitro studies, HLA-DR4 transgenic (DR4) and C57BL/6 (WT) mice were exposed to daily cigarette smoke for 2 months and then harvested for immunofluorescence (IF) staining of lung tissue and ELISA-based analysis of PTM-targeted autoantibody production. Lung tissue from WT mice with bleomycin-induced pulmonary fibrosis was used as a control for PTM formation.

Results: Immunoblots of HBE cell extracts demonstrated smoke-induced citrullination as well as MAA-modification (Figure 1). Similarly, in vivo administration of cigarette smoke induced both citrullination and MAA modification of lung tissue, particularly in DR4 TG mice (Figure 2A). Additional IF staining revealed that these PTMs co-localized with CD19+ B cells and CD64+ macrophages (Figure 2B-D), both of which were increased in the lung tissue of cigarette smoke-exposed DR4 TG mice (p< 0.01 for CD19+ cells and < 0.0001 for CD64+ cells, DR4 TG-smoke vs. WT-smoke). ELISAs also demonstrated preferential formation of anti-MAA antibodies in the serum of DR4 TG mice exposed to cigarette smoke (Figure 3), but a limited profile of ACPA were not detected. Mice showed no evidence of overt arthritis in any of the treatment groups.

Conclusion: For the first time, these studies directly demonstrate that cigarette smoke can induce PTMs such as citrullination and MAA modification in lung tissue/cells. Corresponding development of PTM-targeted immune responses in DR4 TG mice support a paradigm in which cigarette smoke triggers a breach of immune tolerance in immunogenetically predisposed hosts as a foundation for the development of RA/RA-ILD.


Disclosures: A. Gregory, None; C. Kliment, None; G. Thiele, Regeneron, 6; M. Duryee, None; T. Mikuls, Gilead Sciences, 2, Horizon, 2, 5, Pfizer Inc, 2, Sanofi, 2, Bristol-Myers Squibb, 2; B. England, Boehringer-Ingelheim, 2; J. Poole, None; D. Ascherman, None.

To cite this abstract in AMA style:

Gregory A, Kliment C, Thiele G, Duryee M, Mikuls T, England B, Poole J, Ascherman D. Cigarette Smoking Induces Post-translational Protein Modifications in Both in Vitro and in Vivo Models of Rheumatoid Arthritis-associated Interstitial Lung Disease [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/cigarette-smoking-induces-post-translational-protein-modifications-in-both-in-vitro-and-in-vivo-models-of-rheumatoid-arthritis-associated-interstitial-lung-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cigarette-smoking-induces-post-translational-protein-modifications-in-both-in-vitro-and-in-vivo-models-of-rheumatoid-arthritis-associated-interstitial-lung-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology